# 1 each (34*)

**Page range:** 58â€“58

```text
1 each (34*)
Note: Three cases reported more than one AE.
*Percentage is provided as combined for all the Preferred terms mentioned in the respective row
MedDRA Version: 27.0
The first dose latency was reported for 27/69 (39.1%) AEs which ranged from 0 to 594
days with a median of 145 days. Latency from the first dose was unknown for the
remaining AEs (60.9%; 42/69). The event outcome was not reported/unknown for 37
(37/69; 53.6%) events, 10 (10/69; 14.5%) had resolved, five (5/69; 7.2%) were resolving,
and 17 (17/69; 24.6%) events did not resolve.
Risk factor analysis was not performed for these cases as per strategy provided in
Section 2.3.1. The case line listings are presented in Appendix 9.
```